Navigation Links
American Oriental Bioengineering Comments on Earthquake
Date:5/15/2008

NEW YORK, May 15 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China, today released the following statement regarding the earthquake in China:

"Our thoughts are with the many victims of China's earthquake and we are thankful to report that none of our staff was hurt in the tragic events. Our manufacturing, production and overall operations were not impacted by the earthquake and we do not anticipate any damage-related impact to our sales in the second quarter," stated Mr. Tony Liu, Chairman and Chief Executive Officer of American Oriental Bioengineering.

About American Oriental Bioengineering Inc.

American Oriental Bioengineering Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China. For more information, visit http://www.bioaobo.com.

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, including the Form 10-K for the year ended December 31, 2007, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research
2. American Oriental Bioengineering Reports First Quarter 2008 Financial Results
3. LifeQuest World Launches Immune System Boosting Supplement to the North American Market
4. American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health
5. YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING
6. Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research
7. American Oriental Bioengineering to Report First Quarter 2008 Financial Results
8. FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research
9. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
10. SPO Medical Retains American Capital Ventures for Investor Relations Services
11. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... BIRMINGHAM, AL (PRWEB) , ... June 28, 2017 ... ... of new spinal technologies, is pleased to announce the 500th case using the ... fusion system with uniquely designed titanium screws. SiCure can be implanted in ...
(Date:6/28/2017)... ... 2017 , ... Supplies of the critical medical isotope molybdenum-99 (Mo-99) are secure ... Nuclear Medicine and Molecular Imaging (SNMMI) 2017 annual meeting in Denver, Colorado in June. ... to 40 million nuclear medicine procedures worldwide every year. (1) , Sally Schwarz, ...
(Date:6/27/2017)... Shirley, NY (PRWEB) , ... June 27, 2017 , ... ... lift assist and ambulation aid in one device. This assistive aid lifts patients safely ... a safety harness and motorized lift mechanics. The Mobility Assist is the latest in ...
(Date:6/26/2017)... , ... June 26, 2017 , ... ... Melissa Kirkegaard, the former Associate Director of Product Development R&D at Allergan and ... pharmaceutical products at both start-up and established biopharma companies, has joined the firm ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):